“Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials.”, Clin Infect Dis, vol. 59 Suppl 7, pp. S428-36, 2014.
, “Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.”, JAMA, vol. 311, no. 17, pp. 1760-9, 2014.
, “Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.”, J Infect Dis, vol. 217, no. suppl_1, pp. S33-S39, 2018.
, “Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).”, J Infect Dis, vol. 217, no. suppl_1, pp. S65-S74, 2018.
, “Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.”, Vaccine, vol. 36, no. 52, pp. 8054-8061, 2018.
, “The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.”, J Infect Dis, vol. 217, no. suppl_1, pp. S6-S15, 2018.
, “Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.”, Vaccine, vol. 38, no. 33, pp. 5355-5363, 2020.
,